gusevlab.org valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
Meta Tags
Title gusevlab
Description gusev lab Research People Papers Resources Join/Contact Gusev Lab is based in the Dana-Farber Cancer Institute / Harvard Medical School and affiliated wit
Keywords N/A
Server Information
WebSite gusevlab favicongusevlab.org
Host IP 52.217.91.205
Location United States
Related Websites
Site Rank
More to Explore
gusevlab.org Valuation
US$2,200,120
Last updated: 2023-05-14 07:58:15

gusevlab.org has Semrush global rank of 4,810,786. gusevlab.org has an estimated worth of US$ 2,200,120, based on its estimated Ads revenue. gusevlab.org receives approximately 253,860 unique visitors each day. Its web server is located in United States, with IP address 52.217.91.205. According to SiteAdvisor, gusevlab.org is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$2,200,120
Daily Ads Revenue US$2,031
Monthly Ads Revenue US$60,927
Yearly Ads Revenue US$731,117
Daily Unique Visitors 16,924
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
gusevlab.org. A 299 IP: 52.217.91.205
gusevlab.org. NS 86400 NS Record: ns-1947.awsdns-51.co.uk.
gusevlab.org. NS 86400 NS Record: ns-737.awsdns-28.net.
gusevlab.org. NS 86400 NS Record: ns-1126.awsdns-12.org.
gusevlab.org. NS 86400 NS Record: ns-161.awsdns-20.com.
HtmlToTextCheckTime:2023-05-14 07:58:15
gusev lab Research People Papers Resources Join/Contact Gusev Lab is based in the Dana-Farber Cancer Institute / Harvard Medical School and affiliated with the Division of Genetics at Brigham & Women’s Hospital and the Broad Institute . We are quantitative geneticists working on methods to understand complex disease. Our research focuses on deciphering the biological mechanisms of disease and response to therapy, and developing accurate predictive models for large clinical cohorts. ⇣ Lab News: 2022 Dec 27 A new method for genomic classification of cancer of unknown primary and identifying optimal treatments (Moon et al. pre-print) Dec 16 Stefan’s paper on germline variants influencing immunotherapy toxicity is now out (Groha et al. Nature Medicine) ? Oct 25 Presentations from our group at ASHG 2022 Sep 30 Our collaboration on ancestry-specific biases in Tumor Mutational Burden (TMB) now out (Nassar, Adib, Alaiwi et al. Cancer Cell) ? Sep 07 Sylvan’s paper on context-specific chromatin
HTTP Headers
HTTP/1.1 200 OK
x-amz-id-2: 93kwbualQyJcIF7lOlTasy9MRZGxr6fhXP+lb+5v2PCfKR0mmmp/ZBpFoCnAcJeZMSoPU3nWdlg=
x-amz-request-id: HH23ST1GE54KYGS6
Date: Thu, 23 Dec 2021 02:06:41 GMT
Last-Modified: Mon, 15 Nov 2021 18:40:44 GMT
ETag: "87591f603802adefc9484865d3a156a1"
Content-Type: text/html
Server: AmazonS3
Content-Length: 12502
gusevlab.org Whois Information
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS